Identification of the minimal active soluble TREM2 sequence for modulating microglial phenotypes and amyloid pathology
Abstract Background TREM2 is a microglial receptor genetically linked to the risk for Alzheimer’s disease (AD). The cerebrospinal fluid (CSF) levels of soluble TREM2 (sTREM2) have emerged as a valuable biomarker for the disease progression in AD and higher CSF levels of sTREM2 are linked to slower c...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2021-12-01
|
| Ráidu: | Journal of Neuroinflammation |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s12974-021-02340-7 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
